Hemotrophic Mycoplasmas Induce Programmed Cell Death in Red Blood CellsFelder K.M.1 · Hoelzle K.1 · Ritzmann M.2 · Kilchling T.3 · Schiele D.3 · Heinritzi K.3 · Groebel K.1 · Hoelzle L.E.1,4
1Institute of Veterinary Bacteriology, Vetsuisse Faculty, University of Zurich, Zurich,2Clinic for Swine, University of Veterinary Medicine, Vienna,3Clinic for Swine, Ludwig-Maximilians-University Munich, Munich,4Institute of Environmental and Animal Hygiene and Veterinary Medicine (with Animal Clinic), University Hohenheim, Stuttgart
Prof. Dr. L. E. Hoelzle
Institute of Environmental and Animal Hygiene
and Veterinary Medicine (with Animal Clinic),
Garbenstrasse 30, D-70599 Stuttgart (Germany)
Tel. +49 711 459-22427, Fax +49 711 459-22431
Do you have an account?
Hemotrophic mycoplasmas (HM) are uncultivable bacteria found on and in the red blood cells (RBCs). The main clinical sign of HM infections is the hemolytic anemia. However, anemia-inducing pathogenesis has not been totally clarified. In this work we used the splenectomized pig as animal model and Mycoplasma suis as a representative for hemotrophic mycoplasmas to study anemia pathogenesis. Eryptosis, i.e. programmed cell death of RBCs, is characterized by cell shrinkage, microvesiculation and phosphatidylserine (PS) exposure on the outer membrane. The eryptosis occurrence and its influence on anemia pathogenesis was observed over the time-course of M. suis infections in pigs using 3 M. suis isolates of differing virulence. All 3 isolates induced eryptosis, but with different characteristics. The occurrence of eryptosis could as well be confirmed in vitro: serum and plasma of an acutely ill pig induced PS exposure on erythrocytes drawn from healthy pigs. Since M. suis is able to induce eryptotic processes it is concluded that eryptosis is one anemia-inducing factor during M. suis infections and, therefore, plays a significant role in the pathogenesis of infectious anemia due to HM infection.
© 2011 S. Karger AG, Basel
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.